In VivoIn recent years, China’s medical equipment industry has been driven by results of the combined effect of multiple factors; a limited share for domestic companies in the high-cost market, coupled with
Medtech InsightIn recent years, China’s medical equipment industry has been driven by results of the combined effect of multiple factors; a limited share for domestic companies in the high-cost market, coupled with
In VivoIn 2023, China was the second largest product/technology exporter in the global biopharmaceutical pipeline, with 143 pipeline transactions, runner up only to the US. In China’s biopharmaceutical indus
Medtech InsightIf they care to reflect, medtechs will remember 2022 and the lead into 2023 as one of the most challenging periods the industry has seen in decades. On top of the COVID-19 pandemic, which continued to